Literature DB >> 15100583

Cervical human papillomavirus infection in women attending gynaecological outpatient clinics in northern Greece.

T Agorastos1, K Dinas, B Lloveras, F X Bosch, J R Kornegay, J N Bontis, S de Sanjose.   

Abstract

Human papillomavirus (HPV) is the necessary cause for the development of invasive cervical cancer. Identification of HPV determinants may contribute to the targeting of high-risk groups for cervical cancer. The study was aimed at estimating HPV prevalence and its determinants among 1296 women attending six gynaecological outpatient clinics in northern Greece. Information was available through personal interview and the study of cervical exfoliated cells. HPV DNA was detected by reverse line-blot polymerase chain reaction using the L1 primers PGMY09/11. The overall HPV prevalence was 2.5%. After controlling for potential confounders, the two independent risk factors associated with an increased prevalence were young age and parity. The prevalence odds ratio (POR) for those younger than 27 years against those older than 42 years was 5.31 (95% confidence interval (CI)=1.53-18.44) and the POR for nulliparous women compared with women with two or more children was 4.15 (95% CI=1.35-12.76). HPV was present in 10 of 12 women with low-grade cervical intraepithelial lesions (CIN) (83.3%) and in 3 of 4 with high-grade CIN (75%). The prevalence of genital HPV infections in the study population was among the lowest ever reported internationally.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100583     DOI: 10.1097/00008469-200404000-00010

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  5 in total

Review 1.  Human papillomavirus infection by anatomical site among Greek men and women: a systematic review.

Authors:  Savas Tsikis; Lea Hoefer; Angella Charnot-Katsikas; John A Schneider
Journal:  Eur J Cancer Prev       Date:  2016-11       Impact factor: 2.497

2.  Prevalence of HPV infection among Greek women attending a gynecological outpatient clinic.

Authors:  Petroula Stamataki; Athanasia Papazafiropoulou; Ioannis Elefsiniotis; Margarita Giannakopoulou; Hero Brokalaki; Eleni Apostolopoulou; Pavlos Sarafis; George Saroglou
Journal:  BMC Infect Dis       Date:  2010-02-15       Impact factor: 3.090

3.  Population-based study of human papillomavirus infection and cervical neoplasia in Athens, Greece.

Authors:  C Kroupis; G Thomopoulou; T G Papathomas; N Vourlidis; A C Lazaris
Journal:  Epidemiol Infect       Date:  2007-06-07       Impact factor: 2.451

4.  Performance evaluation of manual and automated (MagNA pure) nucleic acid isolation in HPV detection and genotyping using Roche Linear Array HPV Test.

Authors:  Aikaterini Chranioti; Evangelia Aga; Niki Margari; Christine Kottaridi; Asimakis Pappas; Ioannis Panayiotides; Petros Karakitsos
Journal:  Infect Dis Obstet Gynecol       Date:  2011-07-09

5.  Vaccination against human papillomavirus among 865 female students from the health professions in central Greece: a questionnaire-based cross-sectional study.

Authors:  Dimitrios Papagiannis; George Rachiotis; Emmanouil K Symvoulakis; Alexandros Daponte; Ioanna N Grivea; George A Syrogiannopoulos; Christos Hadjichristodoulou
Journal:  J Multidiscip Healthc       Date:  2013-11-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.